Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Zantac Poisoned Heartburn Patients for 35 Years, Lawsuit Claims November 14, 2019 Irvin Jackson Add Your Comments According to allegations raised in a product liability lawsuit filed by a Florida man, side effects of Zantac have poisoned American consumers with high levels of the cancer-causing chemical NDMA for more than 35 years. In a complaint (PDF) filed last week in the U.S. District Court for the Northern District of Florida, Philip McDonald indicates that he developed stomach cancer following use of Zantac, which resulted in the need for several rounds of chemotherapy and surgery. The lawsuit seeks damages from Sanofi, Boehringer Ingelheim and GlaxoSmithKline, who manufactured and sold versions of Zantac or generic equivalents containing the pharmaceutical ingredient ranitidine, which has recently been found to break down inside the body, resulting in the known carcinogen N-Nitrosodimethylamine (NDMA). ZANTAC LAWSUITS Did you or a loved one take recalled Zantac? Side effects of Zantac may increase the risk of cancer, due to chemical impurities found in the heartburn drug. Learn More SEE IF YOU QUALIFY FOR COMPENSATION ZANTAC LAWSUITS Did you or a loved one take recalled Zantac? Side effects of Zantac may increase the risk of cancer, due to chemical impurities found in the heartburn drug. Learn More SEE IF YOU QUALIFY FOR COMPENSATION According to allegations raised in the lawsuit, the manufacturers knew or should have known Zantac was poisoning users of the heartburn drug since the early 1980s, when the medication was first introduced. “When laboratory researchers want to study tumors in experimental animals, the toxin of choice to induce tumors in experimental animals is often N-Nitrosodimethylamine,” McDonald notes in the lawsuit. “Unfortunately, the manufacturers of Zantac have been poisoning American consumers with extremely high levels of NDMA for over 35 years.” McDonald indicates he took Zantac for six years, before he was diagnosed with stomach cancer in June. He indicates that the cancer was caused by NDMA in Zantac, and that if the manufacturers had warned himself and other consumers about the risk, they would not have taken the drug and would have used an alternative treatment for heartburn. The case comes after a number of drug makers have issued Zantac recalls in recent months, removing ranitidine-containing drugs from the market due to the risk of NDMA poisoning. Zantac (ranitidine) has been widely used by millions of Americans for treatment of heart burn and acid reflux. However, independent testing recently discovered that each pill contains levels of NDMA that far exceed the permissible daily intake levels set by the FDA. NDMA is a chemical byproduct, which has been linked to reports of kidney cancer, stomach cancer, bladder cancer, small intestine cancer, liver cancer and other digestive tract cancers when contaminating other medications. While the FDA’s permissible daily intake limit for NDMA is 96 ng, the online pharmacy Valisure recently determined that some Zantac tablets contain up to 3,000,000 ng of NDMA; 29,000 times the daily limit. In September, Valisure filed a Citizens Petition, which calls for the drug to be recalled from the market, leading the FDA has issued warnings about the potential risk of Zantac NDMA contamination, which the agency is continuing to investigate. As lawyers continue to investigate potential Zantac cancer claims over the coming months and years, it is widely expected that hundreds, if not thousands, of lawsuits similar to the one brought by McDonald may be filed against manufacturers of the drugs. Tags: Boehringer Ingelheim, Cancer, GlaxoSmithKline, Heartburn, Heartburn Drug, NDMA, Sanofi, Stomach Cancer, Zantac More Zantac Lawsuit Stories Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall June 18, 2025 Jury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim February 5, 2025 Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California November 22, 2024 1 Comments Michael November 16, 2019 Been taking Ranitidine for a few years. Now I have diverticulitis and need to have surgery. Is there a connection? Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025) Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: yesterday) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: yesterday) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)